HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oren Marco Selected Research

Collagen

1/2019Discoidin domain receptors: A promising target in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oren Marco Research Topics

Disease

3Melanoma (Melanoma, Malignant)
12/2020 - 01/2019
2Neoplasms (Cancer)
03/2019 - 01/2019
1Dermatofibrosarcoma
05/2021

Drug/Important Bio-Agent (IBA)

2Tyrosine Kinase InhibitorsIBA
05/2021 - 01/2019
1Imatinib Mesylate (Gleevec)FDA Link
05/2021
1Mitogen-Activated Protein KinasesIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
03/2019
1Messenger RNA (mRNA)IBA
03/2019
1Discoidin Domain Receptor 1IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Discoidin Domain ReceptorsIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1CollagenIBA
01/2019

Therapy/Procedure

1Neoadjuvant Therapy
05/2021
1Precision Medicine
12/2020
1Therapeutics
03/2019